Evidence map›Paper›PMID 37109482›Full record

ArticleLife (Basel, Switzerland)2023

Dermatology Publications on COVID-19 during the First Pandemic Year: Creativity or Opportunism?

Paolo Amerio, Federica Giuliani, Marco Coppola, Fabio Lobefaro, Giulio Gualdi

Abstract read
In one paragraph

Article in Life (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Paolo AmerioDeparment of Medicine and Aging Science, UOC Dermatologia University of Chieti-Pescara, 66100 Chieti, Italy.ORCID 0000-0003-1589-9672
Federica GiulianiDeparment of Medicine and Aging Science, UOC Dermatologia University of Chieti-Pescara, 66100 Chieti, Italy.
Marco CoppolaDeparment of Medicine and Aging Science, UOC Dermatologia University of Chieti-Pescara, 66100 Chieti, Italy.
Fabio LobefaroDeparment of Medicine and Aging Science, UOC Dermatologia University of Chieti-Pescara, 66100 Chieti, Italy.
Giulio GualdiDeparment of Medicine and Aging Science, UOC Dermatologia University of Chieti-Pescara, 66100 Chieti, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDermatologists had to face several challenges during the COVID-19 pandemic. In this scenario, a large amount of data has been produced and published.

objectivesWe present a literature analysis of publications on COVID-19 in the dermatology field in the first year of the pandemic.

methodsThe research was carried out by searching the PubMed database using keywords related to "COVID-19" combined with the keyword "Dermatology" in the "affiliation" search field and collecting articles published from February 2020 to December 2020.

resultsA total of 816 publications from 57 countries were retrieved. Overall, publications increased notably along the timespan considered in this study and appeared to be closely linked to pandemic progression in different countries. In addition, article types (i.e., commentaries, case reports, original research) appeared to be strictly influenced by the pandemic's progression. However, the number and category of these publications may raise questions regarding the scientific relevance of the messages reported.

conclusionsOur analysis provides a descriptive quantitative analysis and suggests that publications do not always respond to real scientific needs but are sometimes linked to a need/opportunity for publication.

Indexed as

COVID-19dermatologypublication

Identifiers

PMID37109482
PMCPMC10146749

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.